{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:20:38Z","timestamp":1767666038653,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303158\/2020-4"],"award-info":[{"award-number":["303158\/2020-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"DOI":"10.1007\/s12687-023-00695-3","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:03:00Z","timestamp":1704211380000},"page":"163-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Empowerment of genetic information by women at-risk of being carriers of Duchenne and Becker muscular dystrophies"],"prefix":"10.1007","volume":"15","author":[{"given":"Alice Maria Luderitz","family":"Hoefel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Augusto","family":"Weschenfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Faria","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina Carvalho","family":"Donis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas Alex Morales","family":"Saute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"4","key":"695_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1590\/1413-81232017224.26862016","volume":"22","author":"MV Albuquerque","year":"2017","unstructured":"Albuquerque MV, Viana ALD, Lima LD, Ferreira MP, Fusaro ER, Iozzi FL (2017) Regional health inequalities: changes observed in Brazil from 2000\u20132016. Cien Saude Colet 22(4):1055\u20131064","journal-title":"Cien Saude Colet"},{"key":"695_CR2","doi-asserted-by":"publisher","unstructured":"American academy of pediatrics section on cardiology and cardiac surgery (2005) Cardiovascular health supervision for individuals affected by duchenne or becker muscular dystrophy. Pediatrics 116(6):1569\u20131573. https:\/\/doi.org\/10.1542\/peds.2005-2448","DOI":"10.1542\/peds.2005-2448"},{"issue":"9629","key":"695_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","volume":"371","author":"S Aym\u00e9","year":"2008","unstructured":"Aym\u00e9 S, Kole A, Groft S (2008) Empowerment of patients: lessons from the rare diseases community. Lancet 371(9629):2048\u20132051","journal-title":"Lancet"},{"issue":"4","key":"695_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM (2018) DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347\u2013361","journal-title":"Lancet Neurol"},{"issue":"3","key":"695_CR5","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1542\/peds.2008-2643","volume":"123","author":"JK Bobo","year":"2009","unstructured":"Bobo JK, Kenneson A, Kolor K, Brown MA (2009) Adherence to American Academy of Pediatrics recommendations for cardiac care among female carriers of Duchenne And Becker muscular dystrophy. Pediatrics 123(3):e471\u2013e475","journal-title":"Pediatrics"},{"issue":"12","key":"695_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.nmd.2016.09.008","volume":"26","author":"L Bogue","year":"2016","unstructured":"Bogue L, Peay H, Martin A, Lucas A, Ramchandren S (2016) Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy. Neuromuscul Disord 26(12):860\u2013864","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"695_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/pme-2021-0153","volume":"19","author":"C Bonilla","year":"2022","unstructured":"Bonilla C, Albuquerque Sortica V, Schuler-Faccini L, Matijasevich A, Scheffer MC (2022) Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine. Per Med 19(6):549\u2013563","journal-title":"Per Med"},{"issue":"8","key":"695_CR8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","volume":"77","author":"PR Clemens","year":"2020","unstructured":"Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, Smith EC, McDonald CM, Zaidman CM, Morgenroth LP, Osaki H, Satou Y, Yamashita T, Hoffman EP (2020) CINRG DNHS Investigators. Safety, tolerability, and efficacy of viltolarsen in boys with Duchenne muscular dystrophy amenable to exon 53 skipping: a phase 2 randomized clinical trial. JAMA Neurol 77(8):982\u2013991","journal-title":"JAMA Neurol"},{"key":"695_CR9","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1200\/EDBK_238937","volume":"39","author":"SA Cohen","year":"2019","unstructured":"Cohen SA, Bradbury A, Henderson V, Hoskins K, Bednar E, Arun BK (2019) Genetic counseling and testing in a community setting: quality, access, and efficiency. Am Soc Clin Oncol Educ Book 39:e34\u2013e44","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"695_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jmg.15.5.339","volume":"15","author":"AM Davie","year":"1978","unstructured":"Davie AM, Emery AE (1978) Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet 15(5):339\u2013345","journal-title":"J Med Genet"},{"key":"695_CR11","doi-asserted-by":"crossref","unstructured":"Dragojlovic N, Borle K, Kopac N, Ellis U, Birch P, Adam S, Friedman JM, Nisselle A (2020) GenCOUNSEL Study; Elliott AM, Lynd LD The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review. Genet Med. 22(9):1437\u20131449","DOI":"10.1038\/s41436-020-0825-2"},{"issue":"5","key":"695_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/jgc4.1151","volume":"28","author":"L Eekhoff","year":"2019","unstructured":"Eekhoff L, Edwards J, Martin A, Prijoles EJ (2019) Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy. J Genet Couns 28(5):993\u20131002","journal-title":"J Genet Couns"},{"issue":"5","key":"695_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/(SICI)1096-8628(19991029)86:5<447::AID-AJMG10>3.0.CO;2-P","volume":"86","author":"S Eggers","year":"1999","unstructured":"Eggers S, Pavanello RC, Passos-Bueno MR, Zatz M (1999) Genetic counseling for childless women at risk for Duchenne muscular dystrophy. Am J Med Genet 86(5):447\u2013453","journal-title":"Am J Med Genet"},{"issue":"5","key":"695_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s10897-018-0251-7","volume":"27","author":"A Goldman","year":"2018","unstructured":"Goldman A, Metcalfe A, MacLeod R (2018) The process of disclosure: mothers\u2019 experiences of communicating X-linked carrier risk information to at-risk daughters. J Genet Couns 27(5):1265\u20131274","journal-title":"J Genet Couns"},{"key":"695_CR15","unstructured":"Government Accountability Office (GAO) (2020)\u00a0https:\/\/www.gao.gov\/assets\/gao-20-593.pdf"},{"issue":"5","key":"695_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejmg.2018.11.015","volume":"62","author":"PE Grant","year":"2019","unstructured":"Grant PE, Pampaka M, Payne K, Clarke A, McAllister M (2019) Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale. Eur J Med Genet 62(5):324\u2013334","journal-title":"Eur J Med Genet"},{"issue":"3","key":"695_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10897-015-9898-5","volume":"25","author":"B Hayes","year":"2016","unstructured":"Hayes B, Hassed S, Chaloner JL, Aston CE, Guy C (2016) Duchenne muscular dystrophy: a survey of perspectives on carrier testing and communication within the family. J Genet Couns 25(3):443\u2013453","journal-title":"J Genet Couns"},{"key":"695_CR18","doi-asserted-by":"publisher","unstructured":"Horovitz DD, de Faria Ferraz VE, Dain S, Marques-de-Faria AP (2013) Genetic services and testing in Brazil. J Community Genet. 4(3):355\u2013375. https:\/\/doi.org\/10.1007\/s12687-012-0096-y","DOI":"10.1007\/s12687-012-0096-y"},{"issue":"7","key":"695_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1467-9566.2009.01177.x","volume":"31","author":"C Huyard","year":"2009","unstructured":"Huyard C (2009) Who rules rare disease associations? A framework to understand their action. Sociol Health Illn 31(7):979\u2013993","journal-title":"Sociol Health Illn"},{"issue":"8","key":"695_CR20","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41436-021-01162-5","volume":"23","author":"BD Jenkins","year":"2021","unstructured":"Jenkins BD, Fischer CG, Polito CA, Maiese DR, Keehn AS, Lyon M, Edick MJ, Taylor MRG, Andersson HC, Bodurtha JN, Blitzer MG, Muenke M, Watson MS (2021) The 2019 US medical genetics workforce: a focus on clinical genetics. Genet Med 23(8):1458\u20131464","journal-title":"Genet Med"},{"issue":"16","key":"695_CR21","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.2169\/internalmedicine.0163-17","volume":"57","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Hatakeyama T, Ishizaki M, Adachi K, Morita M, Yonemoto N, Matsumura T, Toyoshima I, Kimura E (2018) Medical attitudes survey for female dystrophinopathy carriers in Japan. Intern Med 57(16):2325\u20132332","journal-title":"Intern Med"},{"issue":"8","key":"695_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/s41436-018-0417-6","volume":"21","author":"DR Maiese","year":"2019","unstructured":"Maiese DR, Keehn A, Lyon M, Flannery D, Watson M (2019) Working groups of the national coordinating center for seven regional genetics service collaboratives. Current conditions in medical genetics practice. Genet Med 21(8):1874\u20131877","journal-title":"Genet Med"},{"issue":"9464","key":"695_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(05)71146-6","volume":"365","author":"M Marmot","year":"2005","unstructured":"Marmot M (2005) Social determinants of health inequalities. Lancet 365(9464):1099\u20131104","journal-title":"Lancet"},{"key":"695_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-7374-3_3","volume":"1687","author":"SI Mavrogeni","year":"2018","unstructured":"Mavrogeni SI, Markousis-Mavrogenis G, Papavasiliou A, Papadopoulos G, Kolovou G (2018) Cardiac involvement in Duchenne muscular dystrophy and related dystrophinopathies. Methods Mol Biol 1687:31\u201342","journal-title":"Methods Mol Biol"},{"issue":"5","key":"695_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M, Wood AM, Dunn G, Shiloh S, Todd C (2011) The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet 79(5):413\u2013424","journal-title":"Clin Genet"},{"issue":"10101","key":"695_CR26","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E (2017) Clinical Evaluator Training Group; ACT DMD Study Group. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390(10101):1489\u20131498","journal-title":"Lancet"},{"issue":"6","key":"695_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3233\/JND-210643","volume":"8","author":"CM McDonald","year":"2021","unstructured":"McDonald CM, Shieh PB, Abdel-Hamid HZ, Connolly AM, Ciafaloni E, Wagner KR, Goemans N, Mercuri E, Khan N, Koenig E, Malhotra J, Zhang W, Han B, Mendell JR (2021) The Italian DMD Telethon Registry Study Group, Leuven NMRC Registry Investigators, CINRG Duchenne Natural History Investigators, and PROMOVI Trial Clinical Investigators. Open-label evaluation of eteplirsen in patients with Duchenne muscular dystrophy amenable to Exon 51 skipping: PROMOVI trial. J Neuromuscul Dis 8(6):989\u20131001","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"695_CR28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","volume":"77","author":"JR Mendell","year":"2020","unstructured":"Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR (2020) Assessment of systemic delivery of rAAVrh74.MHCK7. micro-dystrophin in children with Duchenne muscular dystrophy: a nonrandomized controlled trial. JAMA Neurol 77(9):1122\u20131131","journal-title":"JAMA Neurol"},{"issue":"10213","key":"695_CR29","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, B\u00f6nnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394(10213):2025\u20132038","journal-title":"Lancet"},{"key":"695_CR30","doi-asserted-by":"crossref","unstructured":"Mitelman O, Abdel-Hamid HZ, Byrne BJ, Connolly AM, Heydemann P, Proud C, Shieh PB, Wagner KR, Dugar A, Santra S, Signorovitch J, Goemans N; investigators from the LNMRC Natural History study, McDonald CM (2022) investigators from the CINRG Duchenne National History Study, Mercuri E; investigators from The DMD Italian Group, Mendell JR. A combined prospective and retrospective comparison of long-term functional outcomes suggests delayed loss of ambulation and pulmonary decline with long-term eteplirsen treatment. J Neuromuscul Dis 9(1):39\u201352","DOI":"10.3233\/JND-210665"},{"key":"695_CR31","unstructured":"Minist\u00e9rio da Educa\u00e7\u00e3o (MEC) (2018)\u00a0http:\/\/portal.mec.gov.br\/index.php?option=com_docman&view=download&alias=102841-matriz-genetica-medica&category_slug=novembro-2018-pdf&Itemid=30192"},{"issue":"3","key":"695_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/0028-3886.43442","volume":"56","author":"JJ Nadkarni","year":"2008","unstructured":"Nadkarni JJ, Dastur RS, Viswanathan V, Gaitonde PS, Khadilkar SV (2008) Duchenne and Becker muscular dystrophies: an Indian update on genetics and rehabilitation. Neurol India 56(3):248\u2013253","journal-title":"Neurol India"},{"issue":"11","key":"695_CR33","doi-asserted-by":"publisher","first-page":"104018","DOI":"10.1016\/j.ejmg.2020.104018","volume":"63","author":"M Segundo-Ribeiro","year":"2020","unstructured":"Segundo-Ribeiro M, Bacal\u00e1 BT, Alvarenga WA, Nascimento LC, McAllister M, Fl\u00f3ria-Santos M (2020) Adaptation and preliminary validation of the genetic counseling outcome scale (GCOS-24) in a Brazilian genetic counseling setting. Eur J Med Genet 63(11):104018","journal-title":"Eur J Med Genet"},{"issue":"8","key":"695_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nmd.2010.05.010","volume":"20","author":"P Soltanzadeh","year":"2010","unstructured":"Soltanzadeh P, Friez MJ, Dunn D, von Niederhausern A, Gurvich OL, Swoboda KJ, Sampson JB, Pestronk A, Connolly AM, Florence JM, Finkel RS, B\u00f6nnemann CG, Medne L, Mendell JR, Mathews KD, Wong BL, Sussman MD, Zonana J, Kovak K, Gospe SM Jr, Gappmaier E, Taylor LE, Howard MT, Weiss RB, Flanigan KM (2010) Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord 20(8):499\u2013504","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"695_CR35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/jgc4.1429","volume":"30","author":"MSO Ting","year":"2021","unstructured":"Ting MSO, Clarke A, McAllister M (2021) Assessing sensitivity to change of the genomics outcome scale (GOS). J Genet Couns 30(6):1767\u20131772","journal-title":"J Genet Couns"},{"issue":"7","key":"695_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00439-016-1666-6","volume":"135","author":"E Viggiano","year":"2016","unstructured":"Viggiano E, Ergoli M, Picillo E, Politano L (2016) Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Hum Genet 135(7):685\u2013698","journal-title":"Hum Genet"},{"issue":"3","key":"695_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/ajmg.1320150314","volume":"15","author":"M Zatz","year":"1983","unstructured":"Zatz M (1983) Effects of genetic counseling on Duchenne muscular dystrophy families in Brazil. Am J Med Genet 15(3):483\u2013490","journal-title":"Am J Med Genet"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-023-00695-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-023-00695-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-023-00695-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T10:19:39Z","timestamp":1713521979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-023-00695-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1007\/s12687-023-00695-3","relation":{},"ISSN":["1868-6001"],"issn-type":[{"type":"electronic","value":"1868-6001"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}